Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (351-360 of 403) with videos related to

Pageof 41
Sort By:
Blood|October 18, 2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationEffie W Petersdorf, Theodore A Gooley, Mari Malkki, et al.
Leukemia & Lymphoma|January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysisJan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Haematologica|February 13, 2023
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trialLeo Ruhnke, Christoph Röllig, Sylvia Herold, et al.
Nature Medicine|January 7, 2026
Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
JAMA Oncology|February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical TrialMartin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Nature Medicine|December 13, 2016
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
Blood|January 16, 2010
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaCyrus Khandanpour, Christian Thiede, Peter J M Valk, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
Blood|June 14, 2014
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosisTobias Herold, Klaus H Metzeler, Sebastian Vosberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2018
Epigenetic alterations in longevity regulators, reduced life span, and exacerbated aging-related pathology in old father offspring miceKan Xie, Devon P Ryan, Brandon L Pearson, et al.
Pageof 41

Showing results (351-360 of 403) with videos related to

Sort By:
Pageof 41
Blood|October 18, 2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationEffie W Petersdorf, Theodore A Gooley, Mari Malkki, et al.
Leukemia & Lymphoma|January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysisJan M Middeke, Raphael Teipel, Christoph Röllig, et al.
Haematologica|February 13, 2023
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trialLeo Ruhnke, Christoph Röllig, Sylvia Herold, et al.
Nature Medicine|January 7, 2026
Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
JAMA Oncology|February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical TrialMartin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Nature Medicine|December 13, 2016
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
Blood|January 16, 2010
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaCyrus Khandanpour, Christian Thiede, Peter J M Valk, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
Blood|June 14, 2014
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosisTobias Herold, Klaus H Metzeler, Sebastian Vosberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2018
Epigenetic alterations in longevity regulators, reduced life span, and exacerbated aging-related pathology in old father offspring miceKan Xie, Devon P Ryan, Brandon L Pearson, et al.
Pageof 41